Sphingolipidoses in Turkey

Brain and Development

Volumn 26, Issue 6, 2004, Pages 363-366

  Asuman Özkara, Hatice ^a   Topçu, Meral ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Incidence; Lysosomal enzymes; Sphingolipidoses

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CEREBROSIDE SULFATASE; GALACTOSYLCERAMIDASE; LYSOSOME ENZYME;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BLOOD SAMPLING; CORRELATION ANALYSIS; FETUS; GLOBOID CELL LEUKODYSTROPHY; HUMAN; INCIDENCE; INFANT; LIPIDOSIS; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; METACHROMATIC LEUKODYSTROPHY; PATIENT SELECTION; PREGNANCY; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; RISK FACTOR; SANDHOFF DISEASE; SCREENING TEST; TURKEY (REPUBLIC); UMBILICAL CORD BLOOD;

ALPHA-GALACTOSIDASE; BETA-GALACTOSIDASE; BETA-N-ACETYLHEXOSAMINIDASE; CEREBROSIDE-SULFATASE; CEREBROSIDES; CHILD, PRESCHOOL; CHORIONIC VILLI SAMPLING; ENZYMES; FABRY DISEASE; FEMALE; FETAL DISEASES; GLUCOSYLCERAMIDASE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LYSOSOMES; MASS SCREENING; PREGNANCY; SPHINGOLIPIDOSES; SPHINGOLIPIDS; TURKEY;

EID: 3242722272     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2003.09.006     Document Type: Article

References (23)

1. Neufeld E.F. Lysosomal storage diseases. Annu Rev Biochem. 60:1991;257-280
2. Barth P.G. Disorders of sphingolipid metabolism. Fernandes J., Saudubray J.M., van den Berghe G. Inborn metabolic diseases. 3rd ed. :2000;401-413 Springer-Verlag, Berlin
3. Conzelmann E., Sandhoff K. Biochemical basis of late-onset neurolipidoses. Dev Neurosci. 13:1991;197-204
4. Leinekugel P., Michel S., Conzelmann E., Sandhoff K. Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet. 88:1992;513-523
5. Özkara H.A., Arikan M.C., Topcu M., Emre S., Renda Y. A study on enzyme activities of some sphingolipidoses. Turk J Pediatr. 36:(3):1994;215-221
6. Özkara H.A., Akerman B.R., Ciliv G., Topçu M., Renda Y., Gravel R.A. Donor splice site mutation in intron 5 of the Hex A gene in a Turkish infant with Tay-Sachs disease. Hum Mutat. 5:1995;186-187
7. Özkara H.A., Navon R. At least six different mutations in Hex A gene cause Tay-Sachs disease among the Turkish population. Mol Genet Metab. 65:1998;250-253
8. Özkara H.A., Topçu M., Renda Y. Sandhoff disease in the Turkish population. Brain Dev. 19:1997;469-472
9. Özkara H.A., Sandhoff K. Characterization of two Turkish beta-hexosaminidase mutations causing Tay-Sachs disease. Brain Dev. 25:(3):2003;191-194
10. Özkara H.A., Sandhoff K. A new point mutation (G412 to A) at the last nucleotide of exon 3 of hexosaminidase alpha-subunit gene affects splicing. Brain Dev. 25:(3):2003;203-206
11. Sinici İ., Özkara H.A., Topcu M., Ciliv G. Biochemical and molecular characterization of mutant hexosaminidase A in a Turkish family. Pediatr Int. 45:(1):2003;16-22
12. Lowry O.H., Rosebrough N.J., Farr L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275
13. Suzuki K. Enzymatic diagnosis of sphingolipidoses. Ginsburg V. Methods in enzymol. vol. 138:1987;727-763 Academic Press, Florida
14. Besley G.T., Gatt S. Spectrophotometric and fluorometric assays of galactocerebrosidase activity, their use in the diagnosis of Krabbe's disease. Clin Chim Acta. 110:1981;19-26
15. Von Figura K., Gieselman V., Jaeken J. Metachromatic leukodystrophy. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. 8th ed. The metabolic and molecular basis of inherited disease. vol. III:2001;3695-3725 McGraw-Hill, New York
16. Poorthuis B.J., Wevers R.A., Kleijer W.J., Groener J.E., de Jong J.G., van Weely S., et al. The frequency of lysosomal storage diseases in the Netherlands. Hum Genet. 105:1999;151-156
17. Meikle P.J., Hopwood J.J., Clague A.E., Carey W.F. Prevalence of lysosomal storage disorders. J Am Med Assoc. 281:1999;249-254
18. Heim P., Claussen M., Hoffmann B., Conzelmann E., Gartner J., Harzer K., et al. Leukodystrophy incidence in Germany. Am J Med Genet. 71:1997;475-478
19. Wenger D.A., Suzuki K., Suzuki Y., Suzuki K. Galactosylceramide lipidosis: Globoid cell leukodystrophy (Krabbe disease). Scriver C.R., Beaudet A.L., Sly W.S., Valle D. 8h ed. The metabolic and molecular basis of inherited disease. vol. III:2001;3669-3695 McGraw-Hill, New York
20. Gravel R.A., Kaback M.M., Proia R.L., Sandhoff K., Suzuki K., Suzuki K. The GM2 gangliosidoses. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. 8th ed. The metabolic and molecular basis of inherited disease. vol. III:2001;3827-3877
21. Beutler E., Grabowski G.A. Gaucher disease. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. 8th ed. The metabolic and molecular basis of inherited disease. vol. III:2001;3635-3669 McGraw-Hill, New York
22. Suzuki Y., Oshima A., Nanba E. Beta-galactosidase deficiency (beta-galactosidosis): GM1 gangliosidosis and Morquio B disease. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. 8th ed. The metabolic and molecular basis of inherited disease. vol. III:2001;3775-3811 McGraw-Hill, New York
23. Desnick R.J., Ioannou Y.A., Eng C.M. α-Galactosidase A deficiency: Fabry disease. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. 8th ed. The metabolic and molecular basis of inherited disease. vol. III:2001;3733-3775 McGraw-Hill, New York